NEURONTIN
Generic: GABAPENTIN
Viatris Specialty LLCManufacturer
ORALRoute
GABAPENTINActive Substance
1998-10-09Original Approval
NEURONTIN is FDA application NDA020882, sponsored by VIATRIS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
29,887 reports
2
FATIGUE
25,265 reports
3
NAUSEA
23,025 reports
4
PAIN
21,365 reports
5
OFF LABEL USE
20,051 reports
6
DIARRHOEA
18,346 reports
7
HEADACHE
18,088 reports
8
DIZZINESS
16,383 reports
9
FALL
15,680 reports
10
DYSPNOEA
14,449 reports